Table of Contents

Marquette Intellectual Property Law Review Volume 19 | Issue 2 Article 1 Table of Contents Follow this and additional works at: http://scholarship.law.marquette.edu/iplr Part of the Intellectual Property Commons Repository Citation Table of Contents, 19 Marq. Intellectual Property L. Rev. (2015). Available at: http://scholarship.law.marquette.edu/iplr/vol19/iss2/1 This Prefatory Matter is brought to you for free and open access by the Journals at Marquette Law Scholarly Commons. It has been accepted for inclusion in Marquette Intellectual Property Law Review by an authorized administrator of Marquette Law Scholarly Commons. For more information, please contact . MARQUETTE INTELLECTUAL PROPERTY LAW REVIEW Volume 19 Summer 2015 Number 2 ARTICLES PRODUCT HOPPING 2.0: GETTING THE FDA TO YANK YOUR ORIGINAL LICENSE BEATS STACKING PATENTS Lars Noah ...................................................................................................... 161 COPYRIGHTS WITHOUT LIMITS—THE UNDEFEATABLE RIGHT OF ACCESS CONTROL UNDER §1201(A) OF THE DIGITAL MILLENNIUM COPYRIGHT ACT Kristian D. Stout, Esq. ................................................................................... 181 THE EMERGING RIGHT TO COMMUNAL INTELLECTUAL PROPERTY Enninya S. Nwauche ...................................................................................... 221 MYLAN V. WARNER CHILCOTT: A STUDY IN PHARMACEUTICAL PRODUCT HOPPING Vikram Iyengar .............................................................................................. 245 COMMENTS NOW IS THAT WHAT I CALL MUSIC?: POST-MODERN CLASSICAL MUSIC AND COPYRIGHT LAW Jamie M. Yu ................................................................................................... 269 PUBLIC K-12 TEACHERS CREATION OF NONTRADITIONAL EDUCATIONAL WORKS: TO RELY ON THE TEACHER EXCEPTION OR EXPLORE OTHER OPTIONS? Katheryn Mills ............................................................................................... 289 HART-SCOTT-RODINO & CHEVRON STEP ZERO: CAN THE FTC TARGET THE PHARMACEUTICAL INDUSTRY? Tyler Leverington........................................................................................... 309  (...truncated)